Lantheus Holdings (LNTH) Operating Expenses (2014 - 2026)
Lantheus Holdings' (LNTH) quarterly Operating Expenses came in at $96.9 million in Q1 2026, down 2.42% year-on-year from $99.3 million in Q1 2025, and up 288.99% on a QoQ basis from -$51.3 million in Q4 2025.
Lantheus Holdings (LNTH) Operating Expenses (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has 13 years of Operating Expenses data on file, last reported at $96.9 million in Q1 2026.
- On a quarterly basis, Operating Expenses fell 2.42% year-over-year to $96.9 million in Q1 2026; TTM through Mar 2026 was $283.1 million, a 38.22% decrease from a year earlier, with the FY2025 full-year figure at $286.3 million, down 20.86% from the prior year.
- Operating Expenses for Q1 2026 stood at $96.9 million, up from -$51.3 million in the prior quarter.
- Over the last five years, Operating Expenses for LNTH reached as high as $260.2 million in Q4 2022 and fell as low as -$51.3 million in Q4 2025.
- Historically, Operating Expenses has averaged $89.2 million across 5 years, with a median of $76.5 million in 2024.
- Across the five-year window, Operating Expenses jumped 344.78% in 2022 and sank 126.99% in 2025, its largest moves.
- Year by year, Operating Expenses stood at $260.2 million in 2022, then plunged by 53.44% to $121.1 million in 2023, then surged by 56.81% to $190.0 million in 2024, then tumbled by 126.99% to -$51.3 million in 2025, then jumped by 288.99% to $96.9 million in 2026.
- Per Business Quant data, the three most recent Operating Expenses figures were $96.9 million in Q1 2026, -$51.3 million in Q4 2025, and $129.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1.00 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 788.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 12.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 455.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.24 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 621.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 494.00 Mn |
| 10 | Lantheus Holdings | 6.72 Bn | 6.22 Bn | 230.92 Mn | 96.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 96.91 Mn |
| Dec 31, 2025 | -51.28 Mn |
| Sep 30, 2025 | 129.92 Mn |
| Jun 30, 2025 | 107.56 Mn |
| Mar 31, 2025 | 99.32 Mn |
| Dec 31, 2024 | 189.97 Mn |
| Sep 30, 2024 | 76.52 Mn |
| Jun 30, 2024 | 92.44 Mn |
| Mar 31, 2024 | 75.90 Mn |
| Dec 31, 2023 | 121.15 Mn |
| Sep 30, 2023 | 73.14 Mn |
| Jun 30, 2023 | 42.05 Mn |
| Mar 31, 2023 | 55.89 Mn |
| Dec 31, 2022 | 260.18 Mn |
| Sep 30, 2022 | 49.17 Mn |
| Jun 30, 2022 | 47.33 Mn |
| Mar 31, 2022 | 49.79 Mn |
| Dec 31, 2021 | 58.50 Mn |
| Sep 30, 2021 | 39.80 Mn |
| Jun 30, 2021 | 55.24 Mn |